Global Peripheral Vascular Interventions Market Size By Type (Stent, Balloon), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

lobal Peripheral Vascular Interventions Market Report Description

The Global Peripheral Vascular Interventions Market was valued at USD 10.7 billion in 2023 and is expected to surpass USD 18.9 billion by 2031, growing at a CAGR of 7.2% during the forecast period from 2023 to 2031. Peripheral vascular interventions (PVIs) refer to minimally invasive procedures aimed at treating peripheral artery disease (PAD), particularly in lower limbs. Market growth is driven by the increasing prevalence of PAD, advancements in stent and catheter technologies, and rising demand for minimally invasive surgeries. Additionally, an aging population and greater awareness of vascular health are propelling market expansion.

Drivers

1. Rising Prevalence of Peripheral Artery Disease:

PAD affects millions globally, particularly among aging populations. The increasing incidence of diabetes, hypertension, and obesity further contributes to the rising demand for peripheral vascular interventions.

2. Technological Advancements in Devices:

The introduction of drug-coated balloons (DCBs), bioresorbable stents, and advanced imaging-guided catheter systems have improved the efficacy and safety of interventions, encouraging adoption.

3. Shift Toward Minimally Invasive Procedures:

Healthcare systems and patients increasingly prefer minimally invasive techniques due to shorter recovery times, reduced hospital stays, and lower risk of complications.

Restraints

1. High Costs and Limited Reimbursement in Some Regions:

The high cost of peripheral vascular devices and procedures, coupled with limited reimbursement frameworks in developing markets, poses a barrier to widespread adoption.

2. Risk of Restenosis and Device-Related Complications:

Despite technological progress, concerns remain regarding restenosis (re-narrowing of vessels) and procedural complications, which may restrain market growth.

Opportunity

1. Emerging Markets and Healthcare Infrastructure Expansion:

Countries in Asia-Pacific, Latin America, and the Middle East are investing in healthcare infrastructure and expanding access to advanced cardiovascular care, presenting untapped growth opportunities.

2. Integration of AI and Imaging in Interventions:

The use of artificial intelligence and image-guided systems in vascular procedures is set to enhance diagnostic accuracy and procedural success, opening new avenues for innovation and market expansion.

Market by System Type Insights

Based on system type, the Stents segment dominated the market in 2023, owing to high adoption rates in PAD treatment. Drug-eluting and self-expanding stents have particularly gained traction due to their ability to reduce restenosis. The Catheters and Guidewires segment is expected to witness the highest growth, driven by their indispensable role in complex procedures and advancements in flexibility and navigation precision.

Market by End-use Insights

The Hospitals segment emerged as the largest end-use category in 2023, accounting for over 60% of the market share. Hospitals are primary centers for vascular surgeries and procedures. The Ambulatory Surgical Centers (ASCs) segment is anticipated to grow rapidly during the forecast period, supported by cost-effectiveness, shorter recovery times, and growing acceptance of outpatient endovascular procedures.

Market by Regional Insights

North America led the global market in 2023, fueled by a high prevalence of PAD, favorable reimbursement policies, and a robust network of vascular specialists and healthcare infrastructure. Asia-Pacific is expected to witness the fastest growth, driven by improving healthcare access, increased government initiatives for cardiovascular health, and a large base of undiagnosed PAD patients in countries like China and India.

Competitive Scenario

Key players operating in the Global Peripheral Vascular Interventions Market include:

Medtronic plc

Boston Scientific Corporation

Abbott Laboratories

Cook Medical

Terumo Corporation

B. Braun Melsungen AG

Cardinal Health

BD (Becton, Dickinson and Company)

Koninklijke Philips N.V.

Biotronik SE & Co. KG

These companies are actively engaged in mergers & acquisitions, new product launches, and strategic partnerships. For instance:

In 2024, Boston Scientific launched a new generation drug-eluting stent specifically designed for below-the-knee procedures.

Medtronic announced in 2023 the acquisition of a startup specializing in AI-powered intravascular imaging systems.

Scope of Work – Global Peripheral Vascular Interventions Market

Report Metric Details

Market Size (2023) USD 10.7 billion

Projected Market Size (2031) USD 18.9 billion

CAGR (2023–2031) 7.2%

Market Segments By System Type (Stents, Catheters, Balloons, Guidewires), By End-use (Hospitals, ASCs, Specialty Clinics), By Region

Growth Drivers Rising prevalence of PAD, Technological advancements, Demand for minimally invasive procedures

Opportunities Emerging markets, AI integration in imaging-guided interventions

Key Market Developments

April 2024: Abbott Laboratories received FDA approval for its next-gen drug-coated balloon designed to treat femoropopliteal artery disease.

January 2024: Terumo Corporation launched an AI-assisted vascular access platform to improve procedure accuracy in peripheral interventions.

September 2023: Biotronik introduced an ultra-low profile peripheral stent platform in Europe, aimed at improving outcomes in small vessel interventions.

FAQs

1. What is the current market size of the Global Peripheral Vascular Interventions Market?

The market size was valued at USD 10.7 billion in 2023.

2